Takara Bio Takara Bio USA Developing High-Throughput Multiplex Panels in Partnership With Clinical Labs Premium The laboratory-developed tests can be validated and customized by customers, which the firm says engenders increased flexibility. Takara Bio USA, BioExcel Diagnostics Partner for Infectious Disease Panels The firms will partner to offer a range of multiplex syndromic panels to detect infectious disease pathogens and antimicrobial resistance markers. Takara Bio USA Wins European Patent Challenge Filed by Jumpcode Genomics Over NGS Library Prep The patent, granted in 2019, is part of Takara's portfolio covering methods used in RNA-sequencing library prep kits containing ZapR technology. Adaptive Biotechnologies, Takara Bio T Cell Receptor Sequencing Methods Rank High in Benchmarking Study Premium An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample. Takara Bio Forays Into Diagnostic Space With SmartChip COVID-19 Testing Premium The firm's SmartChip platform consists of a high-throughput liquid dispenser and a PCR instrument and can provide more than 5,000 reactions in one run. Jun 8, 2020 Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method Apr 14, 2020 New Studies Compare, Set Benchmarks for Single-Cell RNA Sequencing Methods Premium Feb 20, 2020 Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics for Late-Stage Liver Disease Jun 21, 2017 Takara, Formulatrix Develop Miniaturized Single-Cell Sequencing Workflows Feb 15, 2017 WaferGen Expects 62 Percent Rise in Q4 Revenues Jan 18, 2017 Takara Bio USA Holdings Completes Acquisition of Rubicon Genomics Dec 15, 2016 Takara Bio USA to Acquire Rubicon Genomics Dec 15, 2016 WaferGen Regains Compliance With Nasdaq Listing Requirements Nov 28, 2016 WaferGen Enacts Reverse Stock Split Nov 16, 2016 Wafergen Stockholders Approve Takara Bio Merger Nov 8, 2016 WaferGen Q3 Revenues Up 20 Percent on SmartChip Sales Nov 1, 2016 Takara Bio USA Inks RNA-seq Supply Deal With Allen Institute for Brain Science Oct 31, 2016 WaferGen Releases Preliminary Q3 Results, Urges Stockholders to Vote for Takara Merger Aug 9, 2016 WaferGen Q2 Revenues Jump 56 Percent as Takara Bio Takeover Looms Jun 6, 2016 WaferGen Biosystems, Takara Bio Ink Distribution Deal in Japan May 13, 2016 Takara Bio to Acquire WaferGen Biosystems May 10, 2016 WaferGen Biosystems Q1 Revenues Up 68 Percent Apr 26, 2016 Takara Bio, IDT Form RNA Sequencing Partnership Mar 8, 2016 WaferGen Q4 Revenues Rise Sharply With Increased SmartChip Sales Jan 28, 2016 WaferGen Expects to Report Sharp Increase in Q4 Revenues Load More Breaking News Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance Adela Closes $48M Financing to Develop Cancer Monitoring, Early Detection Test 3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.